Fundación Centro de Investigaciones Biomédicas Riescard

Espinal 00000

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 2, Dyslipidemia, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed